Microaxial Flow Pump in Infarct-Related Cardiogenic Shock
Jacob E Møller, Christian Hassager
Abstract
To the Editor: The Danish–German Cardiogenic Shock (DanGer Shock) trial conducted by Møller et al. (April 18 issue)1 showed a reduction in all-cause mortality with the use of a microaxial flow pump in a highly selected group of patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock who had a minimal risk of possible hypoxic brain injury. The results are in contrast to those of previous randomized trials of mechanical circulatory support that evaluated intraaortic balloon pumps (IABPs), venoarterial extracorporeal membrane oxygenation, or microaxial flow pumps in this patient population.2-5 These differences may (possibly) be explained by patient selection . . .
Topics & Concepts
Cardiogenic shockCardiologyInternal medicineShock (circulatory)MedicineFlow (mathematics)MechanicsMyocardial infarctionPhysicsMechanical Circulatory Support DevicesCardiac Structural Anomalies and RepairCardiac Arrest and Resuscitation